Full entry information is:


SEARCHBreast Model IDSB_0025 (version 1)
Model Submission Date2015-01-13
Model TypeXenograft
Model Name-
Strain MF1 nude
Sex Female
Site Subcutaneous - flank
Cell LineMDA-MB-436
Material AvailableTumour (-)
Material Storage
Therapy Available Yes
Therapy Control (0.1mls PBS), 100ug/kg zoledronic acid, 2mg/kg doxorubicin or 100ug/kg zoledronic acid followed 24h later by 2mg/kg doxorubicin. All treatments were given once per week for 4 weeks
Analyses Tumour volume; Vascularisation; Apoptosis; Proliferation; Gene expression;
Reference14. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer. Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I. J Natl Cancer Inst. 2008 Aug 20;100(16):1167-78.
PubMed ID18695136
Additional References -
Additional References PubMed IDs-
Study Molecule -
Notes -

  Email to obtain this model (SB_0025)

  Can't find the model you're looking for? Please email for help in obtaining models if you are having difficulty.

  Or alternatively, try the International Mouse Strain Resource (IMSR).